Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00556361 · ClinicalTrials.gov registry record · Phase 2
Use of Ketamine Prior to Cardiopulmonary Bypass in Children
A Phase 2 study of Ventricular Septal Defect, sponsored by Arkansas Children's Hospital Research Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT00556361 is a Phase 2 study of Ventricular Septal Defect that has completed, run by Arkansas Children's Hospital Research Institute. The registered enrollment target is 24 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00556361, a Phase 2 study of Ventricular Septal Defect, has completed, sponsored by Arkansas Children's Hospital Research Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
To assess whether the drug ketamine given prior to cardiopulmonary bypass can decrease injury to the cells in the brain.
Conditions Studied
Interventions
- DRUG ketamine
- DRUG saline
Study Locations (1)
Arkansas
- Arkansas Children's Hospital - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2004-07 |
| Est. Completion | 2007-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00556361
The ClinicalTrials.gov registry entry for NCT00556361 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Arkansas Children's Hospital Research Institute, which has 97 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Ventricular Septal Defect appearing as the primary indexed condition, and to 2 interventions - of which ketamine is the first listed.
NCT00556361 reports 1 study location spanning 1 distinct geographic area - top geographies include Arkansas.
Frequently Asked Questions
What is clinical trial NCT00556361 about?
NCT00556361 is a clinical study titled "Use of Ketamine Prior to Cardiopulmonary Bypass in Children". To assess whether the drug ketamine given prior to cardiopulmonary bypass can decrease injury to the cells in the brain.
What is the current status of trial NCT00556361?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 24 participants. The study started on 2004-07. Estimated completion is 2007-11.
What conditions does trial NCT00556361 study?
This clinical trial studies the following conditions: Ventricular Septal Defect.
What interventions are being tested in trial NCT00556361?
The interventions under investigation include: ketamine (DRUG), saline (DRUG).
Who is sponsoring clinical trial NCT00556361?
This trial is sponsored by Arkansas Children's Hospital Research Institute, which has 97 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00556361 being conducted?
This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.